Diagnostic Center | May 20, 2023
Moderna presents Phase 1/2 of MRNA-3927at 2023 ASGCT Meeting
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
The Awards recognizes standout digital health & medical technology products and companies
Nous-209 has been developed using the Nouscom's viral vector platform
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
The partnership will capitalize on the combined capabilities of the two organizations
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Subscribe To Our Newsletter & Stay Updated
